BE861141A - PHARMACEUTICAL PREPARATIONS WITH SUSTAINED RELEASE OF ACTIVE SUBSTANCES - Google Patents

PHARMACEUTICAL PREPARATIONS WITH SUSTAINED RELEASE OF ACTIVE SUBSTANCES

Info

Publication number
BE861141A
BE861141A BE182882A BE182882A BE861141A BE 861141 A BE861141 A BE 861141A BE 182882 A BE182882 A BE 182882A BE 182882 A BE182882 A BE 182882A BE 861141 A BE861141 A BE 861141A
Authority
BE
Belgium
Prior art keywords
sustained release
active substances
pharmaceutical preparations
preparations
pharmaceutical
Prior art date
Application number
BE182882A
Other languages
French (fr)
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of BE861141A publication Critical patent/BE861141A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE182882A 1976-11-26 1977-11-24 PHARMACEUTICAL PREPARATIONS WITH SUSTAINED RELEASE OF ACTIVE SUBSTANCES BE861141A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74532576A 1976-11-26 1976-11-26
US80010577A 1977-05-24 1977-05-24

Publications (1)

Publication Number Publication Date
BE861141A true BE861141A (en) 1978-03-16

Family

ID=27114439

Family Applications (1)

Application Number Title Priority Date Filing Date
BE182882A BE861141A (en) 1976-11-26 1977-11-24 PHARMACEUTICAL PREPARATIONS WITH SUSTAINED RELEASE OF ACTIVE SUBSTANCES

Country Status (21)

Country Link
JP (1) JPS609697B2 (en)
AR (1) AR218047A1 (en)
AT (1) AT359197B (en)
AU (1) AU511080B2 (en)
BE (1) BE861141A (en)
CA (1) CA1086226A (en)
CH (1) CH639560A5 (en)
DE (1) DE2752728C2 (en)
DK (1) DK150534C (en)
FI (1) FI65910C (en)
FR (1) FR2373288A1 (en)
GB (1) GB1544761A (en)
GR (1) GR61724B (en)
IE (1) IE45998B1 (en)
IL (1) IL53462A (en)
LU (1) LU78584A1 (en)
NL (1) NL182283C (en)
NO (1) NO147626C (en)
NZ (1) NZ185772A (en)
PT (1) PT67323B (en)
SE (1) SE426781B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2929456A1 (en) 1979-07-20 1981-02-05 Lentia Gmbh COMPOSITION WITH EXTENDED BRONCHOLYTIC AND TOCOLYTIC EFFECTIVENESS, A METHOD FOR THE PRODUCTION THEREOF AND BRONCHOLYTIC AND TOKOLYTICALLY ACTIVE AGENT
CA1236023A (en) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Controlled release pharmaceutical preparations
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5188825A (en) * 1989-12-28 1993-02-23 Iles Martin C Freeze-dried dosage forms and methods for preparing the same
EP0542926B1 (en) * 1990-08-07 1995-02-15 Pfizer Inc. Use of interfacially-polymerized membranes in delivery devices
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
US20130230587A1 (en) * 2010-11-10 2013-09-05 Rubicon Research Private Limited Sustained release compositions
FR3059903B1 (en) * 2016-12-08 2019-03-22 Salsarulo Pharma ORAL MEDICINE COMPRISING AN OSMOTIC LAXATIVE INCORPORATED IN A MATRIX BASED ON VEGETABLE FATS
CA3078844A1 (en) * 2017-10-09 2019-04-18 Rhodes Pharmaceuticals L.P. Pharmaceutical resinate compositions and methods of making and using thereof
CN113811488B (en) * 2019-05-23 2024-05-03 吉第联合股份公司 Filling unit for filling containers with liquid products of the pharmaceutical industry

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE550150A (en) * 1955-08-08
GB843118A (en) * 1957-02-13 1960-08-04 Ici Ltd Pharmaceutical compositions containing piperidine derivatives
US3158538A (en) * 1961-02-23 1964-11-24 White Lab Inc Antidiarrheal compositions and method of using
GB982150A (en) * 1961-09-29 1965-02-03 Glaxo Group Ltd Therapeutic resin complexes
US3594470A (en) * 1968-02-19 1971-07-20 Abbott Lab Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin
GB1218102A (en) * 1968-03-15 1971-01-06 Philips Nv Improvements in medicaments comprising drug/ion-exchange resin compounds
CA935092A (en) * 1968-09-03 1973-10-09 S. Banker Gilbert Molecular drug entrapment process and compositions
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
DE2343218C2 (en) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Pellets containing furosemide

Also Published As

Publication number Publication date
FR2373288A1 (en) 1978-07-07
JPS5369822A (en) 1978-06-21
JPS609697B2 (en) 1985-03-12
DK150534B (en) 1987-03-23
DE2752728A1 (en) 1978-06-01
CH639560A5 (en) 1983-11-30
DE2752728C2 (en) 1985-08-01
NO774051L (en) 1978-05-29
SE7713370L (en) 1978-05-27
NL182283C (en) 1988-02-16
NO147626C (en) 1983-05-25
IL53462A0 (en) 1978-01-31
IE45998L (en) 1978-05-26
IL53462A (en) 1980-12-31
IE45998B1 (en) 1983-01-26
CA1086226A (en) 1980-09-23
GR61724B (en) 1978-12-29
ATA848077A (en) 1980-03-15
FI773568A (en) 1978-05-27
FR2373288B1 (en) 1980-06-13
AU3098677A (en) 1979-05-31
AU511080B2 (en) 1980-07-24
LU78584A1 (en) 1978-04-20
NO147626B (en) 1983-02-07
GB1544761A (en) 1979-04-25
NZ185772A (en) 1978-12-18
FI65910C (en) 1984-08-10
PT67323B (en) 1979-04-24
AT359197B (en) 1980-10-27
AR218047A1 (en) 1980-05-15
NL7712996A (en) 1978-05-30
DK523277A (en) 1978-05-27
NL182283B (en) 1987-09-16
PT67323A (en) 1977-12-01
FI65910B (en) 1984-04-30
SE426781B (en) 1983-02-14
DK150534C (en) 1987-10-12

Similar Documents

Publication Publication Date Title
FR2344287A1 (en) ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITIONS
BE871584A (en) PHARMACEUTICAL PREPARATIONS
FR2340727A1 (en) PHARMACEUTICAL PREPARATIONS INTENDED TO REMEDY ABUSE OF NARCOTICS
BE851590A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING PYRETHRINOIDS
AT347588B (en) MEDICINAL ACTIVE SUBSTANCE
SE7709359L (en) PHARMACEUTICAL DOSAGE FORM
NL190664C (en) Substituted benzhydrylpiperidino derivatives with therapeutic activity and pharmaceutical preparations containing these compounds.
FR2304354A1 (en) NEW PHARMACEUTICAL COMPOSITIONS WITH DELAYED ACTIVITY
NO142670C (en) BENZYLPENICILLINESTERS FOR USE AS BASIC MATERIAL IN THE PREPARATION OF A THERAPEUTIC ACTIVE ESTER OF ALFA-AMINOBENZYLPENICILLINES
DK524080A (en) PHARMACEUTICAL AGENTS CONTAINING A CORTICOSTEROID SUBSTANCE
FR2326933A1 (en) CONTROLLED DRUG RELEASE TABLET
BE861141A (en) PHARMACEUTICAL PREPARATIONS WITH SUSTAINED RELEASE OF ACTIVE SUBSTANCES
ATA585776A (en) INSECTICIDAL AND ACARICIDAL AGENT
BE824341A (en) PHARMACEUTICAL COMPOSITIONS WITH ANALGESIC ACTIVITY
ZA772514B (en) Improvements relating to the administration of pharmaceutically active substances to animals
BE838507A (en) PHARMACEUTICAL TABLETS
BE869560R (en) NEW STABLE PHARMACEUTICAL SOLUTIONS AND THEIR PREPARATION
IT7823560A0 (en) MIXTURES OF ACTIVE SUBSTANCES AND THEIR PREPARATION.
BE842348A (en) NEW STABLE PHARMACEUTICAL SOLUTIONS AND THEIR PREPARATION
AR206692A1 (en) DISPENSING AGENT OF SUSTAINED RELEASE OF ACTIVE SUBSTANCES
BE776788A (en) PHARMACEUTICAL PREPARATIONS WITH ANESTHESIC ACTIVITY
SE7705857L (en) PHARMACEUTICAL ACTIVE ASSOCIATIONS
BE853569A (en) MEDICINAL PREPARATIONS
BE848975A (en) CONTRACEPTIVE PHARMACEUTICAL PREPARATIONS
AT347179B (en) INSECTICIDAL AND ACARICIDAL AGENT

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: FISONS CORP.

Effective date: 19971124